✦ LIBER ✦

CCL19 reduces tumour burden in a model of advanced lung cancer

✍ Scribed by Hillinger, S; Yang, S-C; Batra, R K; Strieter, R M; Weder, W; Dubinett, S M; Sharma, S

Book ID: 109998781
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 136 KB
Volume: 94
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6603061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Naringenin reduces lung metastasis in a

Naringenin reduces lung metastasis in a breast cancer resection model

✍ Lei Qin; Lingtao Jin; Linlin Lu; Xiaoyan Lu; Chunling Zhang; Fayun Zhang; Wei Li 📂 Article 📅 2011 🏛 SP Higher Education Press 🌐 English ⚖ 477 KB

Bikunin plus paclitaxel markedly reduces

Bikunin plus paclitaxel markedly reduces tumor burden and ascites in mouse model of ovarian cancer

✍ Hiroshi Kobayashi; Tatsuo Yagyu; Kiyokazu Inagaki; Toshiharu Kondo; Mika Suzuki; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 117 KB

## Abstract Our previous studies of intraperitoneal ovarian carcinoma in a mouse model demonstrated that bikunin gene transfection could prevent ascites formation and intraperitoneal disseminated metastasis. Although ascites was almost completely inhibited, tumor burden was variably reduced. Severa

Arming a replicating adenovirus with ost

Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer

✍ Cody, J J; Rivera, A A; Lyons, G R; Yang, S W; Wang, M; Sarver, D B; Wang, D; Se 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 840 KB

Arming a replicating adenovirus with ost

Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer

✍ Cody, J J; Rivera, A A; Lyons, G R; Yang, S W; Wang, M; Sarver, D B; Wang, D; Se 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

Prognostic value of symptom burden for o

Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer

✍ Xin Shelley Wang; Qiuling Shi; Charles Lu; Ethan M. Basch; Valen E. Johnson; Tit 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

## Abstract ## BACKGROUND: Patient–reported outcomes have shown independent prognostic value for patients with nonsmall cell lung cancer (NSCLC). However, translating patient‐reported outcomes into useful prognostic information for individual patients has been problematic. ## METHODS: A total of

VP-16 plus cyclophosphamide in the treat

VP-16 plus cyclophosphamide in the treatment of advanced lung cancer

✍ J. Estape; A. Milla; A. Agusti; J. Sanchez-Lloret; P. Santabarbara; C. Rozman 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views